Erin Dickman

Erin Dickman

Auto-generated profile, based on publicly available information

Erin Dickman

Oncology Nursing Society, 125 Enterprise Drive, Pittsburgh, PA 15275, USA https://twitter.com/ONSErin

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2023 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
PGPamela Ginex
Pamela Ginex
EDErin Dickman
Erin Dickman
MEMilagros R. Elia
Milagros R. Elia
DBDarcy Burbage
Darcy Burbage
RWRyne Wilson
Ryne Wilson
RMRebecca L. Morgan
Rebecca L. Morgan

31 January 2024 in Cancer Medicine
Verified
Journal Article
Open access
TPTheresia Pichler
Theresia Pichler
FMFriederike Mumm
Friederike Mumm
NDNavdeep Dehar
Navdeep Dehar
EDErin Dickman
Erin Dickman
Celia Diez de los Rios de la SernaCelia Diez de los Rios de la Serna
Celia Diez de los Rios de la Serna
AMAmy C. Moore
Amy C. Moore
Background: Precision oncology, using comprehensive biomarker testing (cBT) to inform individual cancer diagnosis, prognosis and treatment, includes increasingly complex technology and clinical data sets. People impacted by cancer (patients and caregivers) and healthcare professionals (HCPs) face distinct challenges in navigating the cBT and personalized treatment landscape. This review summarizes evidence regarding cBT‐related communication between people impacted by cancer and HCPs and identifies important avenues for future research in precision oncology.Methods: A scoping review was conducted using records published in PubMed during January 2017–August 2022, focusing on the breadth of topics on patient‐HCP communication and knowledge resources used by HCPs as guidance in cBT‐related communication. Data were extracted from records meeting inclusion criteria, and findings were summarized according to main topics.Results: The search identified 287 unique records and data were extracted from 42 records, including nine from expert input. Most records originated from the United States included patients with different types of cancer, and oncologists were the main HCPs. Patients' motivation for undergoing cBT and receiving results was generally high in different settings. However, patients' understanding of cBT‐related concepts was limited, and their knowledge and information preferences changed based on cBT implications and significance to family members. HCPs were valued by patients as a trusted source of information. Limited evidence was available on HCPs' information‐seeking behavior and factors influencing cBT‐related knowledge and confidence, often self‐reported as insufficient.Conclusions: Patient education by knowledgeable and confident HCPs, information management and a caring patient‐HCP relationship communicating continuity of care regardless of cBT results are crucial to empower patients and shared decision‐making in precision oncology. More data on the process and structure of cBT‐related communication, distinction between and characterization of different timepoints of patient‐HCP interactions are needed.

31 January 2025 in Nursing Clinics of North America
Verified
Journal Article
Closed access
EDErin Dickman
Erin Dickman
MSMemnun Seven
Memnun Seven
Celia Diez de los Rios de la SernaCelia Diez de los Rios de la Serna
Celia Diez de los Rios de la Serna

1 April 2024 in Clinical Journal of Oncology Nursing
Verified
Journal Article
Open access
PDF file
EDErin Dickman
Erin Dickman
Genomic science guides cancer care across the cancer trajectory. As members of the interprofessional healthcare team, oncology nurses assess for and support genomic-associated biomarker testing and results management throughout the testing process. Nurses often reinforce patient education from the provider, identify biomarker test results that inform treatment options, and provide emotional support to patients and families affected by the results (Dodson, 2018; Rahman et al., 2022).